# POTASSIUM PHOSPHATES
> **NDA212832** · New Drug Application · Sponsor: FRESENIUS KABI USA · Approved 2019-11-26
## Drug
- **FDA Application Number:** NDA212832
- **Application type:** New Drug Application
- **Brand name:** POTASSIUM PHOSPHATES
- **Generic name:** POTASSIUM PHOSPHATES
- **Active ingredients:** POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** FRESENIUS KABI USA
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2019-11-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212832)
---
*MORVS · CC0 1.0*